More than ever, people are talking about direct-to-patient, decentralized or community-based clinical trials, but sponsors can face major challenges when conducting these studies globally. That’s why it’s important to choose a partner with experience conducting decentralized clinical trials abroad. Decentralized clinical trials improve patient recruitment and retention as well as speed up the overall clinical trial process with 58 percent of people saying that these trials complete an average of three months faster than traditional trials.*
This webinar will discuss this trial design and the benefits they have proven for the clinical trial industry, along with some real-life examples of how MRN have delivered in challenging circumstances. The featured speaker will also discuss how they’re now using their global experience and local Japanese expertise to deliver decentralized clinical trials in Japan.
Register for this webinar to hear MRN’s CEO, Graham Wylie, share the key considerations around implementing these trials, including recommendations on best practices, as well as what the future looks like for decentralized clinical trials in Japan.
*Source: Informa report – Impacts of DCT 2021
Graham Wylie, CEO, MRN
Dr. Graham Wylie, CEO of MRN, has worked in the pharmaceutical industry for over 30 years and has been an agent of change throughout. His career started at Pfizer, spanning clinical trial management, development of global technology platforms and global change management and continued at PAREXEL as a Medical Director and then Vice President of Account Management. He formed MRN as CEO in 2006, which has since become the market-leading Clinical Trial Support Organization in the field of international community-focused trial delivery.Message Presenter
Who Should Attend?
This webinar will benefit those involved in decentralized clinical trials, with relevant job titles including:
- Head of Clinical Operations/COO
- Medical Directors
- Purchasing Manager/Procurement Teams
- Clinical Team Project Manager
- Patient Support Manager
What You Will Learn
Join this webinar to learn about:
- Key considerations around implementing decentralized clinical trials in Japan
- Recommendations on best practices for using decentralized clinical trials
- What the future looks like for decentralized clinical trials in Japan
Our focus is supporting clinical research delivery by helping patients participate in trials, while remaining in their communities, wherever they live around the world. We aim to reduce the inconvenience and disruption of visits to investigator sites as much as feasible by reducing the number of those visits. When visits need to be undertaken, we work to make the process as efficient and convenient as possible. We enhance patient enrolment, recruitment and retention.
As the largest international provider of specialist community clinical trial support, our services set the benchmarks for high-quality and innovative delivery. MRN is at the core of the clinical trial market and everything we do has always been focused on the patient.
Increased patient-centricity is changing clinical research – This is, and always will be, a core part of Medical Research Network’s DNA.